A retrospective observational study on the effectiveness and safety of vedolizumab with or without budesonide induction therapy among patients with moderate-to-severe Crohn's disease

被引：0
|
作者：
Weisshof, R. [1 ]
Vavricka, S. [2 ,3 ]
Pouillon, L. [4 ]
Braegger, F. [5 ]
Roset, M. [6 ]
Bent-Ennakhil, N. [5 ]
Ferrante, M. [7 ]
机构：
[1] Rambam Healthcare Campus, Dept Gastroenterol, Haifa, Israel
[2] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland
[3] Ctr Gastroenterol & Hepatol AG, Zurich, Switzerland
[4] Imeldaziekenhuis Bonheiden, Imelda GI Clin Res Ctr, Bonheiden, Belgium
[5] Takeda Pharmaceut Int AG, Glattpark Opfikon, Switzerland
[6] Real World Solut, IQVIA, Barcelona, Spain
[7] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.410
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P285
引用
收藏
页码：S317 / S318
页数：3
相关论文
共 50 条
  • [1] Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational study
    Roni Weisshof
    Stephan R. Vavricka
    Lieven Pouillon
    Fiona Braegger
    Montserrat Roset
    Nawal Bent-Ennakhil
    Marc Ferrante
    [J]. BMC Gastroenterology, 23
  • [2] Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational study
    Weisshof, Roni
    Vavricka, Stephan R.
    Pouillon, Lieven
    Braegger, Fiona
    Roset, Montserrat
    Bent-Ennakhil, Nawal
    Ferrante, Marc
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [3] Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn's Disease in China
    Zhou, Ting
    Sheng, Yanan
    Guan, Haijing
    [J]. ADVANCES IN THERAPY, 2021, 38 (08) : 4233 - 4245
  • [4] Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China
    Ting Zhou
    Yanan Sheng
    Haijing Guan
    [J]. Advances in Therapy, 2021, 38 : 4233 - 4245
  • [5] The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (03) : 330 - 338
  • [6] A PHASE 3 STUDY OF VEDOLIZUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN JAPANESE PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE
    Ogata, Haruhiko
    Motoya, Satoshi
    Watanabe, Kenji
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Sugiura, Kenkichi
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Watanabe, Mamoru
    Hibi, Toshifumi
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1109 - S1109
  • [7] Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease
    Morales Bermudez, A. I.
    Bracho Gonzalez, M.
    Gomez Rodriguez, P.
    Olmedo Martin, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I489 - I490
  • [8] Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease
    Morales Bermudez, A. I.
    Bracho Gonzalez, M.
    Gomez Rodriguez, P.
    Olmedo Martin, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I489 - I490
  • [9] THE VISIBLE 2 PHASE 3 STUDY OF EFFICACY AND SAFETY OF VEDOLIZUMAB SC FOR MODERATE-TO-SEVERE CROHN'S DISEASE
    Vermeire, Severine
    D'Haens, Geert R.
    Baert, Filip J.
    Danese, Silvio
    Kobayashi, Taku
    Loftus, Edward V.
    Bhatia, Siddharth
    Kisfalvi, Krisztina
    Rosario, Maria
    Zhang, Wenwen
    Sandborn, William J.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S194 - S194
  • [10] Vedolizumab in Mild to Moderate Crohn's Disease Patients Naive to Biological Therapy: a Multicentric Observational Study
    Dotti, A. Z.
    Vilela, E. G.
    Chebli, J. M. F.
    Chebli, L. A.
    Magro, D. O.
    Steinwurz, F.
    Argollo, M.
    Carvalho, N. S.
    Parente, J. M. L.
    Parra, R. S.
    Perin, R. L.
    Flores, C.
    Morsoletto, E. M.
    Ferreira, S. D. C.
    Ludvig, J. C.
    Kaiser, R. L., Jr.
    Queiroz, N. S. F.
    Faria, M. A. G.
    Nicollelli, G. M.
    Andrade, A. R.
    Kotze, P. G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 714 - 715
12345